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I thought this first “Letter from America” should be on independence—the
independence of continuing medical education from industry. In the United States,
accredited continuing medical education is free of the control of entities that
produce, market, re-sell, or distribute health care products or services used by or
on patients. This independence is very important to us. It has become part of the
brand identity of accredited CME in the United States. Independence is one of
the tactics put in place to support two overall strategic imperatives regarding the
validity of accredited CME.
The first imperative is to ensure that accredited CME is never again used as
part of an industry campaign to make or to expand a market for a product. The
second imperative is to ensure that accredited CME never again appears as if
it is being used to make a market for a product or to expand the market for a
product. Before 1990, there were concerns that CME was promotion disguised as
education. There were hearings in the US Congress to address these issues. Since
then industry, the health professions, and the US government's legislative, judicial,
and executive branches have all weighed-in with rules, regulations, guidelines, and
laws in support of one or both of these imperatives. These rules and regulations
form a framework to preserve the credibility and the public interest focus of
accredited CME. As I said, independence together with content validity is part of
the brand identity of accredited CME in the United States.
Interestingly, in 2008 and 2009, it became apparent to the CME community
that a conflict had developed when some CME providers tried to fully incorporate
the ACCME's independence regulations by preventing industry representatives
from serving as CME faculty. The requirements were identified as a barrier,
preventing industry from reporting its research at accredited CME events. The
CME leadership of accredited organizations correctly said, “No industry speakers.”
The research leadership said, “The ACCME is blocking the dissemination of
important new science.” We were at an impasse because the research leadership
would not consider excluding industry presentations on research from accredited
CME and the ACCME would not drop its independence requirement.
We found a solution. You can read the complete text of these clarifications at
www.accme.org. There you will find that we determined that people who work for
industry can speak at accredited CME events within certain limits. They can speak
about the discovery process itself, about topics that do not relate to their firm's
business lines, or about research results that are not about products. In addition,
the ACCME accommodated industry reporting about some product research if a
rigorous set of internal controls is in place to control content.
Raynard S. Kington, MD, PhD, then Deputy Director of the National Institutes
of Health, and now President of Grinell College, in 2010 said to the ACCME:
“We applaud the Accreditation Council for Continuing Medical Education's
efforts to provide additional guidance for ensuring research independence and
a free flow of scientific exchange, while safeguarding accredited CME from
commercial influence. Your vigilance in this important matter contributes to the
best practices of unbiased information-sharing and will benefit, ultimately, the
health of the American public.”
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actions to provide clarifications on how to accommodate
the reporting of industry's discovery and innovation—
while preserving the independence of accredited CME.
Industry cannot control the content of accredited CME
and industry employees cannot be faculty—except under
very narrow and relatively rare circumstances.
In America, accredited continuing medical education is
free of the control of entities that produce, market, re-sell,
or distribute health care products or services used by, or
on patients. Independence is important to us.
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